Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000109

Chief Legal Officer sold 5,760 shares at an average $21.43 ($123,459)

  • Chief Legal Officer acquired 5,760 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · Chief Legal Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-01 Exercise or conversion : show line 1 in the form 10b5-1 +5,760 $1.86 $10,714 30,352 D
2024-08-01 Sale : show line 2 in the form 10b5-1 −5,460 $21.39 $116,804 24,892 D
2024-08-01 Sale : show line 3 in the form 10b5-1 −300 $22.18 $6,655 24,592 D
Open-market sales · 5,760 sh · avg $21.43 · $123,459

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-01 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (right to buy) −5,760 82,786 D
Loading xslF345X05/wk-form4_1722553563.xml…